| Line item | 2025-12-31 FY | 2024-12-31 FY | 2023-12-31 FY | 2023-07-28 FY | 2022-12-31 FY | 2021-12-31 FY |
|---|---|---|---|---|---|---|
| Revenue | $2.07M | $2.00M | $0.00 | – | $1.63M | $3.94M |
| Cost of Revenue | – | – | – | – | – | – |
| Gross Profit | – | – | – | – | – | – |
| Operating Expenses | $7.05M | $5.63M | $12.95M | $2.40M | $46.00M | $59.14M |
| R&D | $959.00K | $286.00K | $1.51M | – | $31.49M | $37.64M |
| SG&A | $6.09M | $5.34M | $8.13M | – | $14.50M | $20.62M |
| Operating Income | -$4.97M | -$3.63M | -$12.95M | – | -$44.37M | -$55.20M |
| Interest Expense | – | – | – | – | – | – |
| Tax Expense | $0.00 | $0.00 | $0.00 | – | $0.00 | $0.00 |
| Net Income | -$3.53M | -$3.06M | -$5.26M | – | -$44.08M | -$51.65M |
| EPS (basic) | -1.1100 | -1.2100 | -2.2500 | – | -1.0100 | -1.3200 |
| EPS (diluted) | -1.1100 | -1.2100 | -2.2500 | – | -1.0100 | -1.3200 |
| Shares (diluted) | $3.18M | $2.52M | $2.34M | – | $43.47M | $39.14M |